Li Fan, Zhang Weiling, Hu Huimin, Zhang Yi, Li Jing, Huang Dongsheng
Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, People's Republic of China.
Cancer Manag Res. 2022 Jan 6;14:107-122. doi: 10.2147/CMAR.S343648. eCollection 2022.
It is not clear which known adverse prognostic factors of neuroblastoma are closely associated with tumor recurrence after complete response. We analyzed the factors for post-remission recurrence in children with neuroblastoma through a retrospective study.
A total of 179 children with neuroblastoma who achieved initial complete response were included in this study. Kaplan-Meier method and multivariate Cox regression model were used to assess the factors that may have impact on tumor recurrence after complete response.
The 5-year overall survival rates of the entire cohort (n = 179), recurrence group (n = 86) and non-recurrence group (n = 93) were 81.9%, 66.2%, and 98.7%, respectively. The 5-year recurrence-free survival (RFS) rates of the entire cohort and the high-risk cohort were 47.3% and 31.2%, respectively. RFSs were significantly reduced in children with age ≥18 months, INSS stage 4, unfavorable histology, bone marrow metastasis, osseous metastasis, serum NSE level ≥100 ng/mL, and serum LDH level ≥1400 U/L ( < 0.05). The independent risk factors for post-remission recurrence in the entire cohort were age ≥18 months, unfavorable histology, and serum LDH level ≥1400 U/L ( < 0.05). In the high-risk cohort, the independent risk factor for recurrence was serum LDH ≥1400 U/L ( < 0.05). Based on a new recurrence risk stratification, the 5-year RFSs of the children were 93.5%, 66.4%, and 22.5% in the low-risk, intermediate-risk, and high-risk groups, respectively. The area under the ROC curve of the new stratification was 0.773 (95% CI: 0.704-0.842).
Age ≥18 months, unfavorable histology, and serum LDH level ≥1400 U/L are independent risk factors for post-remission recurrence in children with neuroblastoma. A newly established recurrence risk stratification has diagnostic advantages in predicting risk of recurrence, which is especially suitable for low- and middle-income countries or regions.
尚不清楚神经母细胞瘤已知的哪些不良预后因素与完全缓解后肿瘤复发密切相关。我们通过一项回顾性研究分析了神经母细胞瘤患儿缓解后复发的因素。
本研究纳入了179例最初达到完全缓解的神经母细胞瘤患儿。采用Kaplan-Meier法和多变量Cox回归模型评估可能影响完全缓解后肿瘤复发的因素。
整个队列(n = 179)、复发组(n = 86)和未复发组(n = 93)的5年总生存率分别为81.9%、66.2%和98.7%。整个队列和高危队列的5年无复发生存率(RFS)分别为47.3%和31.2%。年龄≥18个月、国际神经母细胞瘤分期系统(INSS)4期、组织学不良、骨髓转移、骨转移、血清神经元特异性烯醇化酶(NSE)水平≥100 ng/mL以及血清乳酸脱氢酶(LDH)水平≥1400 U/L的患儿RFS显著降低(P<0.05)。整个队列中缓解后复发的独立危险因素为年龄≥18个月、组织学不良以及血清LDH水平≥1400 U/L(P<0.05)。在高危队列中,复发的独立危险因素为血清LDH≥1400 U/L(P<0.05)。基于新的复发风险分层,低危、中危和高危组患儿的5年RFS分别为93.5%、66.4%和22.5%。新分层的受试者工作特征曲线(ROC)下面积为0.773(95%置信区间:0.704 - 0.842)。
年龄≥18个月、组织学不良以及血清LDH水平≥1400 U/L是神经母细胞瘤患儿缓解后复发的独立危险因素。新建立的复发风险分层在预测复发风险方面具有诊断优势,尤其适用于低收入和中等收入国家或地区。